DRUGS MADE IN AMERICA ACQUIS
DMII · NASDAQ
更新于 2026-10-15 05:47:30
- 今日最高
- $10.19
- 今日最低
- $10.19
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $10.19
- 昨日收盘价
- $10.19
- 成交量
- 449
- 市值
- $6.49亿
- 本益比（P/E）
- 49.85X
- 每股收益（EPS）
- $0.80
昨日价格区间
52周价格区间
公司概况
- 板块
- FINANCIAL SERVICES
- 行业
- N/A
- 子行业
- SHELL COMPANIES
- 总部
- 420 LEXINGTON AVENUE, NEW YORK, NY, UNITED STATES, 10170
- 国家
- US
- 上市日期
- 2025-09-25
- 财年截止
- December
- 流通股数
- 6370万
- CIK
- --
- 官方网址
- --
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative players in the pharmaceuticals and biotechnology sectors, prioritizing advancements in domestic drug manufacturing. Leveraging a seasoned management team with considerable industry expertise, DMII aims to execute strategic transactions that respond to market dynamics and foster sustainable practices. The company's mission encompasses enhancing supply chain resilience and promoting U.S. healthcare self-sufficiency, ultimately driving long-term value creation for shareholders and contributing to the growth of the American pharmaceutical landscape.
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$11.22万
2026-03-31
$13.2万
2025-12-31
$104.75万
2025-09-30
$15.55万
净利润
2026-06-30
$439.64万
2026-03-31
$433.78万
2025-12-31
$433.06万
2025-09-30
-$4.61万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$0.06
2026-03-31
$0.06
2025-12-31
$0.06
2025-09-30
$0.00
息税折旧摊销前利润
2026-06-30
-$11.22万
2026-03-31
-$13.2万
2025-12-31
-$104.75万
2025-09-30
-$4.61万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | $0 | $0 | $0 | $0 |
| 营业支出 | $11.22万 | $13.2万 | $104.75万 | $15.55万 |
| 净利润 | $439.64万 | $433.78万 | $433.06万 | -$4.61万 |
| 净利润率 | -- | -- | -- | -- |
| 每股收益 | $0.06 | $0.06 | $0.06 | $0.00 |
| 息税折旧摊销前利润 | -$11.22万 | -$13.2万 | -$104.75万 | -$4.61万 |
| 有效税率 | -- | -- | -- | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。